Norris Medicines Board Meeting on Aug 14 to Approve Unaudited Results

Norris Medicines Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026. The meeting will take place at the company's registered office in Ankleshwar, Gujarat. Additionally, the company has reminded stakeholders that the trading window for dealing in its securities remains closed from July 1, 2026, and will reopen 48 hours after the declaration of the financial results.